Salix mounts search for 64 new reps

They're hiring! Salix Pharmaceuticals, a Raleigh, NC-based drugmaker, is gearing up for a concerted assault on the market for ulcerative colitis and bowel cleansing meds, with plans to add some 64 sales reps. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.